Abstract Delta9‐tetrahydrocannabinol (THC), the main psychoactive component in
Cannabis sativa preparations, exerts its central effects mainly through the G‐protein coupled …

Δ9‐Tetrahydrocannabinol (THC), the main psychoactive ingredient of marijuana, induces
apoptosis in cultured cortical neurons. THC exerts its apoptotic effects in cortical neurons by …

Cannabinoids (CBs) are neuroprotective in vivo and in vitro, but the mechanisms of their
actions are unknown. The aim of this study was to elucidate the signaling pathways that …

The cannabinoid (CB) system is widespread in the central nervous system and is crucial for
controlling a range of neurophysiological processes such as pain, appetite, and cognition …

It is now well established that central effects of Δ9‐tetrahydrocannabinol (THC), the main
psychoactive component of marijuana, are mediated by CB1 cannabinoid receptors …

Cannabinoids protect neurons from excitotoxic injury. We investigated the mechanisms
involved by studying N-methyl-d-aspartate (NMDA) toxicity in cultured murine …

Cannabinoid receptors (CB1‐R) are the target of a novel class of neuromodulators, the
endocannabinoids. Yet, their signalling mechanisms in adult brain are poorly understood …

Cannabinoids, the active components of marijuana and their endogenous counterparts,
exert many of their actions in brain through the seven-transmembrane receptor CB1. This …

Δ9-Tetrahydrocannabinol (THC) and cannabidiol (CBD) are two main cannabinoid
constituents of marijuana and hashish. The pharmacology of Δ9-THC has been extensively …

Previous preclinical studies have demonstrated that cannabidiol (CBD) and cannabigerol
(CBG), two non-psychotomimetic phytocannabinoids from Cannabis sativa, induce …